Alberto Esquenazi

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
Phone215-663-6676
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gal O, Baude M, Deltombe T, Esquenazi A, Gracies JM, Hoskovcova M, Rodriguez-Blazquez C, Rosales R, Satkunam L, Wissel J, Mestre T, S?nchez-Ferro ?, Skorvanek M, Tosin MHS, Jech R. Clinical Outcome Assessments for Spasticity: Review, Critique, and Recommendations. Mov Disord. 2024 Dec 04. PMID: 39629752.
      Citations:    
    2. Esquenazi A, Zorowitz RD, Ashford S, Beneteau M, Maisonobe P, Hannes C, Jacinto J. Longitudinal goal attainment with repeat injections of abobotulinumtoxinA in adults with lower limb spasticity: Results from a prospective observational study. Arch Phys Med Rehabil. 2024 Nov 19. PMID: 39571744.
      Citations:    
    3. Gracies JM, Alter KE, Biering-S?rensen B, Dewald JPA, Dressler D, Esquenazi A, Franco JH, Jech R, Kaji R, Jin L, Lim ECH, Raghavan P, Rosales R, Shalash AS, Simpson DM, Suputtitada A, Vecchio M, Wissel J. Spastic Paresis: A Treatable Movement Disorder. Mov Disord. 2024 Nov 16. PMID: 39548808.
      Citations:    
    4. Bavikatte G, Francisco GE, Jost WH, Baricich A, Duarte E, Tang SFT, Schwartz M, Nelson M, Musacchio T, Esquenazi A. Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study. PM R. 2024 May 30. PMID: 38813838.
      Citations:    
    5. Bavikatte G, Esquenazi A, Dimyan MA, Dashtipour K, Feng W, Mayadev A, Fanning K, Musacchio T, Zuzek A, Francisco GE. Safety and real-world dosing of onabotulinumtoxinA for the treatment of adult spasticity: post hoc analysis of the Adult Spasticity International Registry study. Am J Phys Med Rehabil. 2024 Jan 03. PMID: 38206635.
      Citations:    
    6. Esquenazi A, Bloudek L, Migliaccio-Walle K, Oliveri D, Tung A, Gillard P, Verduzco-Gutierrez M. Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina. J Rehabil Med. 2023 Oct 30; 55:jrm11626. PMID: 37902443.
      Citations:    
    7. Esquenazi A, Zorowitz RD, Ashford S, Maisonobe P, Page S, Jacinto J. Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study. J Rehabil Med. 2023 Oct 05; 55:jrm4257. PMID: 37794845.
      Citations:    
    8. Talaty M, Esquenazi A. Feasibility and outcomes of supplemental gait training by robotic and conventional means in acute stroke rehabilitation. J Neuroeng Rehabil. 2023 Oct 04; 20(1):134. PMID: 37794474.
      Citations:    
    9. Esquenazi A, Jost WH, Turkel CC, Wein T, Dimitrova R. Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023 Jul 01; 102(S1):e32376. PMID: 37499086.
      Citations:    
    10. Esquenazi A. Video enhanced visual analysis of hemiparetic gait muscle selection: A pilot study. Toxicon. 2023 Apr 13; 228:107112. PMID: 37060926.
      Citations:    
    11. Edwards D, Kumar S, Brinkman L, Ferreira IC, Esquenazi A, Nguyen T, Su M, Stein S, May J, Hendrix A, Finley C, Howard E, Cramer SC. Telerehabilitation Initiated Early in Post-Stroke Recovery: A Feasibility Study. Neurorehabil Neural Repair. 2023 Mar 06; 15459683231159660. PMID: 36876946.
      Citations:    
    12. Livolsi C, Conti R, Guanziroli E, Fri?riksson ?, Alexandersson ?, Kristj?nsson K, Esquenazi A, Molino Lova R, Romo D, Giovacchini F, Crea S, Molteni F, Vitiello N. An impairment-specific hip exoskeleton assistance for gait training in subjects with acquired brain injury: a feasibility study. Sci Rep. 2022 11 11; 12(1):19343. PMID: 36369462.
      Citations:    
    13. Cao N, Barcikowski J, Womble F, Martinez B, Sergeyenko Y, Koffer JH, Kwasniewski M, Watanabe T, Xiao R, Esquenazi A. Efficacy of Early Inpatient Rehabilitation of Post COVID 19 Survivors-Single Center Retrospective Analysis. Am J Phys Med Rehabil. 2022 Oct 10. PMID: 36282676.
      Citations:    
    14. Esquenazi A, Elliott M, Lysandropoulos A. Corrections required for Dressler and Johnson 2022. J Neural Transm (Vienna). 2022 10; 129(10):1307-1308. PMID: 36040626.
      Citations:    
    15. Salga M, Gatin L, Deltombe T, Gustin T, Carda S, Marque P, Winston P, Reebye R, Wein T, Esquenazi A, Keenan MA, Molteni F, Zerbinati P, Picelli A, Coroian F, Coulet B, Sturbois-Nachef N, Fontaine C, Yelnik A, Parratte B, Henry P, Venkatakrishnan S, Rigoard P, David R, Denormandie P, Schnitzler A, Allart E, Genet F. International Recommendations to Manage Poststroke Equinovarus Foot Deformity Validated by a Panel of Experts Using Delphi. Arch Phys Med Rehabil. 2022 Aug 27. PMID: 36030892.
      Citations:    
    16. Esquenazi A, Watanabe T, Barcikowski J, Cao N, Sachinwalla E, Kwasniewski M. Impact of Vaccination in the Rate of COVID-19 Staff Infection in an Acute Inpatient Rehabilitation Facility. Am J Phys Med Rehabil. 2021 Nov 01; 100(11):1031-1032. PMID: 34483264.
      Citations:    
    17. Zafonte R, Borg-Stein J, Dillingham T, Esquenazi A, Francisco G, Kim C, Morgenroth D, Paganoni S, Rensing B. Research and Industry Partnerships in Physiatry. Am J Phys Med Rehabil. 2021 10 01; 100(10):990-995. PMID: 33782275.
      Citations:    
    18. Cao N, Packel A, Marcy E, Sprik K, Harold E, Xiao R, Esquenazi A. Implementing Robotic-Assisted Gait Training in Acute Inpatient Stroke Rehabilitation: A Quality Improvement Initiative. J Int Soc Phys Rehabil Med. 2021 Oct-Dec; 4(4):168-173. PMID: 38283707.
      Citations:    
    19. Esquenazi A, Ayyoub Z, Verduzco-Gutierrez M, Maisonobe P, Otto J, Patel AT. AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol. Adv Ther. 2021 11; 38(11):5623-5633. PMID: 34562231.
      Citations:    
    20. Esquenazi A, Francisco GE, Feng W, Baricich A, Gallien P, Fanning K, Zuzek A, Bandari DS, Wittenberg GF. Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study. Arch Phys Med Rehabil. 2021 11; 102(11):2172-2184.e6. PMID: 34245684.
      Citations:    
    21. Bardelli R, Harlaar J, Morone G, Tomba P, Esquenazi A, Benedetti MG. The Codivilla spring: from then to now and beyond. Eur J Phys Rehabil Med. 2021 Dec; 57(6):1012-1019. PMID: 33861038.
      Citations:    
    22. Esquenazi A, Bavikatte G, Bandari DS, Jost WH, Munin MC, Tang SFT, Largent J, Adams AM, Zuzek A, Francisco GE. Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity. PM R. 2021 10; 13(10):1079-1093. PMID: 33151636.
      Citations:    
    23. Jacinto J, Varriale P, Pain E, Lysandropoulos A, Esquenazi A. Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity. Front Neurol. 2020; 11:629181. PMID: 33391178.
      Citations:    
    24. Esquenazi A, Delgado MR, Hauser RA, Picaut P, Foster K, Lysandropoulos A, Gracies JM. Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport?) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020; 11:576117. PMID: 33101184.
      Citations:    
    25. Esquenazi A, Brashear A, Deltombe T, Rudzinska-Bar M, Krawczyk M, Skoromets A, O'Dell MW, Grandoulier AS, Vilain C, Picaut P, Gracies JM. The Effect of Repeated abobotulinumtoxinA (Dysport?) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury. PM R. 2021 05; 13(5):488-495. PMID: 32741133.
      Citations:    
    26. Esquenazi A, Lee S, Watanabe T, Nastaskin A, McKee C, O'Neill J, Scheponik K, May J. A Comparison of the Armeo to Tabletop-assisted Therapy Exercises as Supplemental Interventions in Acute Stroke Rehabilitation: A Randomized Single Blind Study. PM R. 2021 01; 13(1):30-37. PMID: 32358874.
      Citations:    
    27. Awad LN, Esquenazi A, Francisco GE, Nolan KJ, Jayaraman A. The ReWalk ReStore? soft robotic exosuit: a multi-site clinical trial of the safety, reliability, and feasibility of exosuit-augmented post-stroke gait rehabilitation. J Neuroeng Rehabil. 2020 06 18; 17(1):80. PMID: 32552775.
      Citations:    
    28. Francisco GE, Bandari DS, Bavikatte G, Jost WH, McCusker E, Largent J, Zuzek A, Esquenazi A. High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study. Toxicon X. 2020 Sep; 7:100040. PMID: 32875289.
      Citations:    
    29. Carda S, Invernizzi M, Bavikatte G, Bensma?l D, Bianchi F, Deltombe T, Draulans N, Esquenazi A, Francisco GE, Gross R, Jacinto LJ, Moraleda P?rez S, O'dell MW, Reebye R, Verduzco-Gutierrez M, Wissel J, Molteni F. COVID-19 pandemic. What should Physical and Rehabilitation Medicine specialists do? A clinician's perspective. Eur J Phys Rehabil Med. 2020 Aug; 56(4):515-524. PMID: 32434314.
      Citations:    
    30. Jacinto J, Varriale P, Pain E, Lysandropoulos A, Esquenazi A. Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity. Front Neurol. 2020; 11:388. PMID: 32477251.
      Citations:    
    31. Carda S, Invernizzi M, Bavikatte G, Bensma?l D, Bianchi F, Deltombe T, Draulans N, Esquenazi A, Francisco GE, Gross R, Jacinto LJ, Moraleda P?rez S, O'Dell MW, Reebye R, Verduzco-Gutierrez M, Wissel J, Molteni F. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician's view. Ann Phys Rehabil Med. 2020 11; 63(6):554-556. PMID: 32315802.
      Citations:    
    32. Esquenazi A, Stoquart G, Hedera P, Jacinto LJ, Dimanico U, Constant-Boyer F, Brashear A, Grandoulier AS, Vilain C, Picaut P, Gracies JM. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial. PM R. 2020 09; 12(9):853-860. PMID: 32108436.
      Citations:    
    33. Francisco GE, Jost WH, Bavikatte G, Bandari DS, Tang SFT, Munin MC, Largent J, Adams AM, Zuzek A, Esquenazi A. Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study. PM R. 2020 11; 12(11):1120-1133. PMID: 31953896.
      Citations:    
    34. Esquenazi A, Wein TH, Ward AB, Geis C, Liu C, Dimitrova R. Optimal Muscle Selection for OnabotulinumtoxinA Injections in Poststroke Lower-Limb Spasticity: A Randomized Trial. Am J Phys Med Rehabil. 2019 05; 98(5):360-368. PMID: 31003229.
      Citations:    
    35. Esquenazi A, Talaty M. Robotics for Lower Limb Rehabilitation. Phys Med Rehabil Clin N Am. 2019 05; 30(2):385-397. PMID: 30954154.
      Citations:    
    36. Esquenazi A. Comment on "Assessing Effectiveness and Costs in Robot-Mediated Lower Limbs Rehabilitation: A Meta-Analysis and State of the Art". J Healthc Eng. 2018; 2018:7634965. PMID: 30622690.
      Citations:    
    37. Spiess MR, Steenbrink F, Esquenazi A. Getting the Best Out of Advanced Rehabilitation Technology for the Lower Limbs: Minding Motor Learning Principles. PM R. 2018 09; 10(9 Suppl 2):S165-S173. PMID: 30269803.
      Citations:    
    38. Cao N, Esquenazi A. Innovations Influencing Physical Medicine and Rehabilitation. PM R. 2018 Sep; 10(9 Suppl 2):S129-S130. PMID: 30269798.
      Citations:    
    39. Watanabe TK, Esquenazi A, Flanagan S. The Transformation of the Rehabilitation Paradigm Across the Continuum of Care. PM R. 2018 09; 10(9 Suppl 2):S264-S271. PMID: 30269811.
      Citations:    
    40. Esquenazi A, Moon D, Wikoff A, Sale P. Corrigendum to "Hemiparetic gait and changes in functional performance due to OnabotulinumtoxinA injection to lower limb muscles" [Toxicon 107PA (2015) 109-13]. Toxicon. 2018 08; 150:335. PMID: 29799419.
      Citations:    
    41. van Hedel HJA, Severini G, Scarton A, O'Brien A, Reed T, Gaebler-Spira D, Egan T, Meyer-Heim A, Graser J, Chua K, Zutter D, Schweinfurther R, M?ller JC, Paredes LP, Esquenazi A, Berweck S, Schroeder S, Warken B, Chan A, Devers A, Petioky J, Paik NJ, Kim WS, Bonato P, Boninger M. Advanced Robotic Therapy Integrated Centers (ARTIC): an international collaboration facilitating the application of rehabilitation technologies. J Neuroeng Rehabil. 2018 04 06; 15(1):30. PMID: 29625628.
      Citations:    
    42. Wein T, Esquenazi A, Jost WH, Ward AB, Pan G, Dimitrova R. OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial. PM R. 2018 07; 10(7):693-703. PMID: 29330071.
      Citations:    
    43. Turner-Stokes L, Ashford S, Esquenazi A, Wissel J, Ward AB, Francisco G, Lains J, Suputtitada A, Serrano S, Baguley IJ, Barnes M, Simpson DM. A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework. Eur J Phys Rehabil Med. 2018 Aug; 54(4):605-617. PMID: 29265792.
      Citations:    
    44. Esquenazi A, Lee S, Mayer N, Garreta R, Patel A, Elovic E, Koelbel S, Francisco G, Reuter I. Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience. Am J Phys Med Rehabil. 2017 Dec; 96(12):881-888. PMID: 28657917.
      Citations:    
    45. Gracies JM, Esquenazi A, Brashear A, Banach M, Kocer S, Jech R, Khatkova S, Benetin J, Vecchio M, McAllister P, Ilkowski J, Ochudlo S, Catus F, Grandoulier AS, Vilain C, Picaut P. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension. Neurology. 2017 Nov 28; 89(22):2245-2253. PMID: 29093068.
      Citations:    
    46. Francisco GE, Bandari DS, Bavikatte G, Jost WH, Adams AM, Largent J, Esquenazi A. Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics. J Rehabil Med. 2017 Aug 31; 49(8):659-666. PMID: 28805237.
      Citations:    
    47. Esquenazi A, Alfaro A, Ayyoub Z, Charles D, Dashtipour K, Graham GD, McGuire JR, Odderson IR, Patel AT, Simpson DM. OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a?Delphi Panel Approach. PM R. 2017 Oct; 9(10):960-968. PMID: 28286053.
      Citations:    
    48. Esquenazi A, Lee S, Wikoff A, Packel A, Toczylowski T, Feeley J. A Comparison of Locomotor Therapy Interventions: Partial-Body Weight-Supported Treadmill, Lokomat, and G-EO Training in People With Traumatic Brain Injury. PM R. 2017 Sep; 9(9):839-846. PMID: 28093370.
      Citations:    
    49. Esquenazi A, Dashtipour K, Alfaro A, Ayyoub Z, Charles D, Graham GD, McGuire JR, Odderson IR, Patel AT, Simpson DM. Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post-Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm. PM R. 2016 Sep; 8(9S):S276. PMID: 27673106.
      Citations:    
    50. Esquenazi A, Geis C, Wein T, Ward AB, Liu C, Dimitrova R. Poster 312 Muscle Selection Patterns for Injection of OnabotulinumtoxinA in Adult Patients with Post-Stroke Lower-Limb Spasticity Influence Outcome: Results from a Double-Blind, Placebo-Controlled Phase 3 Clinical Trial. PM R. 2016 Sep; 8(9S):S262. PMID: 27673066.
      Citations:    
    51. Moore MG, Esquenazi A, Greenberg NA. Poster 110-B Biomechanical and Functional Benefits of Central Location of Power Wheelchair Drive Controls. PM R. 2016 Sep; 8(9S):S327. PMID: 27673255.
      Citations:    
    52. Esquenazi A, Lee S, Mayer NH, Brashear A, Francisco GE, Yablon EE, Garreta R, Wissel J, Molteni F. Poster 289 Patient Registry of Spasticity Care World Data Analysis Based on Physician Experience. PM R. 2016 Sep; 8(9S):S254. PMID: 27673047.
      Citations:    
    53. Gracies JM, Esquenazi A, Brashear A, Edgley SR, O'Dell M, Hedera P, Rubin BS, Picaut P. Poster 288 Efficacy and Safety of Repeated AbobotulinumtoxinA Injections in Adults with Lower Limb Spasticity. PM R. 2016 Sep; 8(9S):S254. PMID: 27673046.
      Citations:    
    54. Francisco GE, Bandari D, Bavikatte G, Jost WH, Adams AM, Largent J, Esquenazi A. Poster 281 The Adult Spasticity International Registry (ASPIRE Study): Baseline Demographics and Clinical Characteristics of Patients Treated for Spasticity. PM R. 2016 Sep; 8(9S):S251-S252. PMID: 27673038.
      Citations:    
    55. Esquenazi A, Lee S, Wikoff A, Packel A, Toczylowski T, Feeley J. A Randomized Comparison of Locomotor Therapy Interventions: Partial Body Weight Supported Treadmill, Lokomat? and G-Eo? Training in Traumatic Brain Injury. PM R. 2016 Sep; 8(9S):S154. PMID: 27672753.
      Citations:    
    56. Esquenazi A, Talaty M, Jayaraman A. Powered Exoskeletons for Walking Assistance in Persons with Central Nervous System Injuries: A Narrative Review. PM R. 2017 01; 9(1):46-62. PMID: 27565639.
      Citations:    
    57. Baker R, Esquenazi A, Benedetti MG, Desloovere K. Gait analysis: clinical facts. Eur J Phys Rehabil Med. 2016 Aug; 52(4):560-74. PMID: 27618499.
      Citations:    
    58. Simpson DM, Patel AT, Alfaro A, Ayyoub Z, Charles D, Dashtipour K, Esquenazi A, Graham GD, McGuire JR, Odderson I. OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process. PM R. 2017 02; 9(2):136-148. PMID: 27346090.
      Citations:    
    59. Moon D, Esquenazi A. Instrumented Gait Analysis: A Tool in the Treatment of Spastic Gait Dysfunction. JBJS Rev. 2016 06 07; 4(6). PMID: 27486723.
      Citations:    
    60. Talaty M, Patel S, Esquenazi A. A Randomized Comparison of the Biomechanical Effect of Two Commercially Available Rocker Bottom Shoes to a Conventional Athletic Shoe During Walking in Healthy Individuals. J Foot Ankle Surg. 2016 Jul-Aug; 55(4):772-6. PMID: 27079303.
      Citations:    
    61. Fisk JR, DeMuth S, Campbell J, DiBello T, Esquenazi A, Lin RS, Malas B, McGuigan FX, Fise TF. Suggested Guidelines for the Prescription of Orthotic Services, Device Delivery, Education, and Follow-up Care: A Multidisciplinary White Paper. Mil Med. 2016 Feb; 181(2 Suppl):11-7. PMID: 26835739.
      Citations:    
    62. Esquenazi A, Moon D, Wikoff A, Sale P. Hemiparetic gait and changes in functional performance due to OnabotulinumtoxinA injection to lower limb muscles. Toxicon. 2015 Dec 01; 107(Pt A):109-13. PMID: 26272707.
      Citations:    
    63. Esquenazi A. Gait analysis in lower-limb amputation and prosthetic rehabilitation. Phys Med Rehabil Clin N Am. 2014 Feb; 25(1):153-67. PMID: 24287245.
      Citations:    
    64. Esquenazi A. Change is our challenge and our opportunity. PM R. 2014 Jan; 6(1):1-3. PMID: 24439146.
      Citations:    
    65. Nalysnyk L, Papapetropoulos S, Rotella P, Simeone JC, Alter KE, Esquenazi A. OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review. BMC Neurol. 2013 Sep 08; 13:118. PMID: 24011236.
      Citations:    
    66. Talaty M, Esquenazi A, Briceno JE. Differentiating ability in users of the ReWalk(TM) powered exoskeleton: an analysis of walking kinematics. IEEE Int Conf Rehabil Robot. 2013 Jun; 2013:6650469. PMID: 24187286.
      Citations:    
    67. Vachranukunkiet T, Esquenazi A. Pathophysiology of gait disturbance in neurologic disorders and clinical presentations. Phys Med Rehabil Clin N Am. 2013 May; 24(2):233-46. PMID: 23598260.
      Citations:    
    68. Chancellor MB, Elovic E, Esquenazi A, Naumann M, Segal KR, Schiavo G, Smith CP, Ward AB. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions. Toxicon. 2013 Jun 01; 67:129-40. PMID: 23415704.
      Citations:    
    69. Chen C, Leys D, Esquenazi A. The interaction between neuropsychological and motor deficits in patients after stroke. Neurology. 2013 Jan 15; 80(3 Suppl 2):S27-34. PMID: 23319483.
      Citations:    
    70. Esquenazi A, Albanese A, Chancellor MB, Elovic E, Segal KR, Simpson DM, Smith CP, Ward AB. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon. 2013 Jun 01; 67:115-28. PMID: 23220492.
      Citations:    
    71. Esquenazi A, Lee S, Packel AT, Braitman L. A randomized comparative study of manually assisted versus robotic-assisted body weight supported treadmill training in persons with a traumatic brain injury. PM R. 2013 Apr; 5(4):280-90. PMID: 23200117.
      Citations:    
    72. Esquenazi A, Packel A. Robotic-assisted gait training and restoration. Am J Phys Med Rehabil. 2012 Nov; 91(11 Suppl 3):S217-27; quiz S228-31. PMID: 23080038.
      Citations:    
    73. Esquenazi A, Talaty M, Packel A, Saulino M. The ReWalk powered exoskeleton to restore ambulatory function to individuals with thoracic-level motor-complete spinal cord injury. Am J Phys Med Rehabil. 2012 Nov; 91(11):911-21. PMID: 23085703.
      Citations:    
    74. Esquenazi A, Mayer N, Lee S, Brashear A, Elovic E, Francisco GE, Yablon S. Patient registry of outcomes in spasticity care. Am J Phys Med Rehabil. 2012 Sep; 91(9):729-46. PMID: 22469872.
      Citations:    
    75. Zeilig G, Weingarden H, Zwecker M, Dudkiewicz I, Bloch A, Esquenazi A. Safety and tolerance of the ReWalk? exoskeleton suit for ambulation by people with complete spinal cord injury: a pilot study. J Spinal Cord Med. 2012 Mar; 35(2):96-101. PMID: 22333043.
      Citations:    
    76. Frieden RA, Brar AK, Esquenazi A, Watanabe T. Fitting an older patient with medical comorbidities with a lower-limb prosthesis. PM R. 2012 Jan; 4(1):59-64. PMID: 22269454.
      Citations:    
    77. McFarland LV, Hubbard Winkler SL, Heinemann AW, Jones M, Esquenazi A. Unilateral upper-limb loss: satisfaction and prosthetic-device use in veterans and servicemembers from Vietnam and OIF/OEF conflicts. J Rehabil Res Dev. 2010; 47(4):299-316. PMID: 20803400.
      Citations:    
    78. Dougherty PJ, McFarland LV, Smith DG, Esquenazi A, Blake DJ, Reiber GE. Multiple traumatic limb loss: a comparison of Vietnam veterans to OIF/OEF servicemembers. J Rehabil Res Dev. 2010; 47(4):333-48. PMID: 20803402.
      Citations:    
    79. Esquenazi A, Ofluoglu D, Hirai B, Kim S. The effect of an ankle-foot orthosis on temporal spatial parameters and asymmetry of gait in hemiparetic patients. PM R. 2009 Nov; 1(11):1014-8. PMID: 19942187.
      Citations:    
    80. Elovic EP, Esquenazi A, Alter KE, Lin JL, Alfaro A, Kaelin DL. Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity. PM R. 2009 Sep; 1(9):842-51. PMID: 19769919.
      Citations:    
    81. Kohler F, Cieza A, Stucki G, Geertzen J, Burger H, Dillon MP, Schiappacasse C, Esquenazi A, Kistenberg RS, Kostanjsek N. Developing Core Sets for persons following amputation based on the International Classification of Functioning, Disability and Health as a way to specify functioning. Prosthet Orthot Int. 2009 Jun; 33(2):117-29. PMID: 19367515.
      Citations:    
    82. Esquenazi A, Mayer NH, Elia AE, Albanese A. Botulinum toxin for the management of adult patients with upper motor neuron syndrome. Toxicon. 2009 Oct; 54(5):634-8. PMID: 19470335.
      Citations:    
    83. Esquenazi A, Mayer N, Garreta R. Influence of botulinum toxin type A treatment of elbow flexor spasticity on hemiparetic gait. Am J Phys Med Rehabil. 2008 Apr; 87(4):305-10; quiz 311, 329. PMID: 18437721.
      Citations:    
    84. Klein MG, Braitman LE, Costello R, Keenan MA, Esquenazi A. Actual and perceived activity levels in polio survivors and older controls: a longitudinal study. Arch Phys Med Rehabil. 2008 Feb; 89(2):297-303. PMID: 18226654.
      Citations:    
    85. Cioni M, Esquenazi A, Hirai B. Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot. Am J Phys Med Rehabil. 2006 Jul; 85(7):600-6. PMID: 16788391.
      Citations:    
    86. Esquenazi A. Botulinum neurotoxin in muscle overactivity. J Head Trauma Rehabil. 2005 Nov-Dec; 20(6):563-7. PMID: 16304491.
      Citations:    
    87. Klein MG, Keenan MA, Esquenazi A, Costello R, Polansky M. Musculoskeletal pain in polio survivors and strength-matched controls. Arch Phys Med Rehabil. 2004 Oct; 85(10):1679-83. PMID: 15468030.
      Citations:    
    88. Esquenazi A, Mayer NH. Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning. Am J Phys Med Rehabil. 2004 Oct; 83(10 Suppl):S19-29. PMID: 15448574.
      Citations:    
    89. Jankovic J, Esquenazi A, Fehlings D, Freitag F, Lang AM, Naumann M. Evidence-based review of patient-reported outcomes with botulinum toxin type A. Clin Neuropharmacol. 2004 Sep-Oct; 27(5):234-44. PMID: 15602105.
      Citations:    
    90. Esquenazi A. Amputation rehabilitation and prosthetic restoration. From surgery to community reintegration. Disabil Rehabil. 2004 Jul 22-Aug 5; 26(14-15):831-6. PMID: 15497912.
      Citations:    
    91. Esquenazi A. Evaluation and management of spastic gait in patients with traumatic brain injury. J Head Trauma Rehabil. 2004 Mar-Apr; 19(2):109-18. PMID: 15247822.
      Citations:    
    92. Ofluoglu D, Esquenazi A, Hirai B. Temporospatial parameters of gait after obturator neurolysis in patients with spasticity. Am J Phys Med Rehabil. 2003 Nov; 82(11):832-6. PMID: 14566149.
      Citations:    
    93. Mayer NH, Esquenazi A. Muscle overactivity and movement dysfunction in the upper motoneuron syndrome. Phys Med Rehabil Clin N Am. 2003 Nov; 14(4):855-83, vii-viii. PMID: 14580042.
      Citations:    
    94. Keenan MA, Fuller DA, Whyte J, Mayer N, Esquenazi A, Fidler-Sheppard R. The influence of dynamic polyelectromyography in formulating a surgical plan in treatment of spastic elbow flexion deformity. Arch Phys Med Rehabil. 2003 Feb; 84(2):291-6. PMID: 12601663.
      Citations:    
    95. Fuller DA, Keenan MA, Esquenazi A, Whyte J, Mayer NH, Fidler-Sheppard R. The impact of instrumented gait analysis on surgical planning: treatment of spastic equinovarus deformity of the foot and ankle. Foot Ankle Int. 2002 Aug; 23(8):738-43. PMID: 12199388.
      Citations:    
    96. Klein MG, Whyte J, Esquenazi A, Keenan MA, Costello R. A comparison of the effects of exercise and lifestyle modification on the resolution of overuse symptoms of the shoulder in polio survivors: a preliminary study. Arch Phys Med Rehabil. 2002 May; 83(5):708-13. PMID: 11994812.
      Citations:    
    Esquenazi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (238)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _